Brenda Maloney Shafer
Professional Bio
Brenda is a member of Quarles & Brady's Health Law Practice Group. Her practice focuses primarily in health law and, in particular, health care regulatory and transactional work. Along with her law degree, she holds a Master's of Law in Health Law. A particular area of focus is counseling clients regarding compliance with the 340B Drug Pricing Program.
CMS Publishes 340B Drug Acquisition Cost Survey: Respond by May 15, 2020
To Be or Not to 340B Blog ·
HRSA Unveils New 340B Flexibilities During COVID-19 Crisis
To Be or Not to 340B Blog ·
GAO Report Suggests Increased Oversight of 340B Program
To Be or Not to 340B Blog ·
New PBM State Laws Indicate a Shifting Battlefront over 340B Program Drug Pricing
To Be or Not to 340B Blog ·
Interesting 340B Takeaways from 2020 OPPS Proposed Rule
To Be or Not to 340B Blog ·